Boston Common Asset Management LLC Buys 36,101 Shares of Roche Holding AG $RHHBY

Boston Common Asset Management LLC increased its stake in shares of Roche Holding AG (OTCMKTS:RHHBY) by 11.1% during the 2nd quarter, Holdings Channel.com reports. The fund owned 361,833 shares of the company’s stock after purchasing an additional 36,101 shares during the quarter. Boston Common Asset Management LLC’s holdings in Roche were worth $14,682,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Altrius Capital Management Inc grew its position in Roche by 3.6% during the 1st quarter. Altrius Capital Management Inc now owns 189,993 shares of the company’s stock worth $7,818,000 after acquiring an additional 6,545 shares during the last quarter. Bard Financial Services Inc. lifted its holdings in Roche by 25.3% in the 1st quarter. Bard Financial Services Inc. now owns 138,900 shares of the company’s stock worth $5,716,000 after buying an additional 28,050 shares during the period. Rhumbline Advisers lifted its holdings in Roche by 7.4% in the 1st quarter. Rhumbline Advisers now owns 107,252 shares of the company’s stock worth $4,413,000 after buying an additional 7,374 shares during the period. S&CO Inc. lifted its holdings in Roche by 4.1% in the 1st quarter. S&CO Inc. now owns 51,199 shares of the company’s stock worth $2,101,000 after buying an additional 2,014 shares during the period. Finally, Moloney Securities Asset Management LLC lifted its holdings in Roche by 53.8% in the 1st quarter. Moloney Securities Asset Management LLC now owns 40,732 shares of the company’s stock worth $1,672,000 after buying an additional 14,245 shares during the period.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on RHHBY. Hsbc Global Res upgraded Roche from a “hold” rating to a “strong-buy” rating in a report on Thursday. HSBC upgraded Roche from a “hold” rating to a “buy” rating and set a $50.00 price objective for the company in a report on Thursday. Three analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $50.00.

Roche Stock Performance

RHHBY opened at $45.30 on Friday. The business has a 50 day moving average of $40.76 and a 200-day moving average of $40.25. Roche Holding AG has a 52 week low of $34.10 and a 52 week high of $45.46.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.